IE 11 is not supported. For an optimal experience visit our site on another browser.

FDA monitoring rare condition in 100 people with J&J shot


Health officials say they are monitoring an extremely rare side effect found in about 100 people who have received the Johnson & Johnson Covid-19 vaccine. While the chances of developing Guillain-Barré Syndrome remain low, it’s another discouraging development for the troubled vaccine.